Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
59.26
-1.84 (-3.01%)
Nov 5, 2025, 1:25 PM EST - Market open
Bio-Techne Employees
Bio-Techne had 3,100 employees as of June 30, 2025. The number of employees did not change compared to the previous year.
Employees
3,100
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$392,494
Profits / Employee
$25,145
Market Cap
9.23B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 3,100 | 0 | - |
| Jun 30, 2024 | 3,100 | 50 | 1.64% |
| Jun 30, 2023 | 3,050 | 50 | 1.67% |
| Jun 30, 2022 | 3,000 | 400 | 15.38% |
| Jun 30, 2021 | 2,600 | 300 | 13.04% |
| Jun 30, 2020 | 2,300 | 50 | 2.22% |
| Jun 30, 2019 | 2,250 | 250 | 12.50% |
| Jun 30, 2018 | 2,000 | 200 | 11.11% |
| Jun 30, 2017 | 1,800 | 240 | 15.38% |
| Jun 30, 2016 | 1,560 | 204 | 15.04% |
| Jun 30, 2015 | 1,356 | 335 | 32.81% |
| Jun 30, 2014 | 1,021 | 167 | 19.56% |
| Jun 30, 2013 | 854 | 7 | 0.83% |
| Jun 30, 2012 | 847 | 13 | 1.56% |
| Jun 30, 2011 | 834 | 97 | 13.16% |
| Jun 30, 2010 | 737 | -9 | -1.21% |
| Jun 30, 2009 | 746 | 27 | 3.76% |
| Jun 30, 2008 | 719 | 38 | 5.58% |
| Jun 30, 2007 | 681 | 44 | 6.91% |
| Jun 30, 2006 | 637 | 28 | 4.60% |
| Jun 30, 2005 | 609 | 12 | 2.01% |
| Jun 30, 2004 | 597 | 11 | 1.88% |
| Jun 30, 2003 | 586 | 16 | 2.81% |
| Jun 30, 2002 | 570 | 9 | 1.60% |
| Jun 30, 2001 | 561 | 64 | 12.88% |
| Jun 30, 2000 | 497 | 26 | 5.52% |
| Jun 30, 1999 | 471 | 60 | 14.60% |
| Jun 30, 1998 | 411 | 46 | 12.60% |
| Jun 30, 1997 | 365 | -7 | -1.88% |
| Jun 30, 1996 | 372 | 28 | 8.14% |
| Jun 30, 1995 | 344 | 67 | 24.19% |
| Jun 30, 1994 | 277 | 71 | 34.47% |
| Jun 30, 1993 | 206 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TECH News
- 16 minutes ago - Bio-Techne Corporation (TECH) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 6 hours ago - Bio-Techne misses quarterly sales estimates on weak biotech demand - Reuters
- 6 hours ago - Bio-Techne Releases First Quarter Fiscal 2026 Results - PRNewsWire
- 6 hours ago - BIO-TECHNE DECLARES DIVIDEND - PRNewsWire
- 1 day ago - AI-Powered Spatial Biology Workflow from Bio-Techne and Nucleai Enables Predictive Biomarker Discovery in Melanoma Patients - PRNewsWire
- 2 days ago - ScaleReady Announces a G-Rex® Grant has been awarded to Sonoma Biotherapeutics - PRNewsWire
- 8 days ago - Bio-Techne Launches ProximityScope™ Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research - PRNewsWire
- 13 days ago - ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at Children's National Hospital - PRNewsWire